首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2933篇
  免费   232篇
  国内免费   154篇
耳鼻咽喉   24篇
儿科学   17篇
妇产科学   106篇
基础医学   426篇
口腔科学   24篇
临床医学   293篇
内科学   564篇
皮肤病学   30篇
神经病学   199篇
特种医学   72篇
外科学   356篇
综合类   379篇
一般理论   3篇
预防医学   292篇
眼科学   53篇
药学   242篇
  1篇
中国医学   70篇
肿瘤学   168篇
  2023年   39篇
  2022年   81篇
  2021年   115篇
  2020年   82篇
  2019年   89篇
  2018年   110篇
  2017年   81篇
  2016年   95篇
  2015年   104篇
  2014年   141篇
  2013年   132篇
  2012年   196篇
  2011年   253篇
  2010年   136篇
  2009年   74篇
  2008年   140篇
  2007年   148篇
  2006年   138篇
  2005年   165篇
  2004年   125篇
  2003年   89篇
  2002年   78篇
  2001年   61篇
  2000年   84篇
  1999年   102篇
  1998年   49篇
  1997年   54篇
  1996年   22篇
  1995年   23篇
  1994年   21篇
  1993年   23篇
  1992年   28篇
  1991年   28篇
  1990年   16篇
  1989年   19篇
  1988年   23篇
  1987年   16篇
  1986年   12篇
  1985年   12篇
  1984年   6篇
  1983年   8篇
  1982年   7篇
  1981年   8篇
  1980年   6篇
  1979年   14篇
  1974年   5篇
  1973年   6篇
  1972年   5篇
  1970年   11篇
  1968年   5篇
排序方式: 共有3319条查询结果,搜索用时 15 毫秒
61.
Ding  Yufang  Zhao  Jiuliang  Qian  Junyan  Zhang  Li  Zhang  Shangzhu  Jiang  Nan  Li  Jing  Wu  Chanyuan  Wu  Qingjun  Xu  Dong  Leng  Xiaomei  Wang  Qian  Zhang  Wen  Tian  Xinping  Li  Mengtao  Zeng  Xiaofeng 《Clinical rheumatology》2022,41(5):1371-1379
Clinical Rheumatology - To identify the predictive value of anti-ribosomal P protein (anti-RibP) antibodies on the accrual of neuropsychiatric damage in systemic lupus erythematosus (SLE) patients...  相似文献   
62.
目的评估血管内超声(IVUS)指导药物洗脱支架(DES)置入对慢性肾脏病(CKD)患者长期临床结局的影响。方法研究对象来源于ULTIMATE研究,该研究是一项前瞻性、多中心、随机对照研究,从2014年8月到2017年5月在国内8家中心入选1448例置入DES的冠心病患者,按1∶1的比例随机分为两组(接受IVUS或冠状动脉造影指导支架置入)。本研究选取ULTIMATE研究中有基线血肌酐值的患者1443例,分为CKD组和非CKD组。CKD的定义为Cockcroft-Gault(CG)公式得出的估算的肾小球滤过率(eGFR)<60 ml·min-1·1.73 m-2至少3个月。主要终点是术后3年靶血管失败(TVF),包含心原性死亡、靶血管心肌梗死和临床症状驱动的靶血管血运重建。采用Kaplan-Meier法进行生存分析,通过log-rank检验比较各组的终点事件发生情况,并采用Cox风险比例模型计算HR及其95%CI,同时检验交互作用。采用多因素Cox回归分析TVF的独立影响因素。结果本研究共入选1443例置入DES的冠心病患者,其中CKD组349例(24.2%),非CKD组1094例。CKD组中采用IVUS指导支架置入者180例,造影指导支架置入者169例;非CKD组中采用IVUS指导支架置入者543例,造影指导支架置入者551例。3年临床随访率为98.3%(1418/1443)。术后3年时,CKD组的TVF发生率为12.0%(42/349),高于非CKD组的7.4%(81/1094)(P=0.01),其差异主要来源于CKD组更高的心原性死亡率[4.6%(16/349)比1.5%(16/1094),P<0.001]。CKD组中IVUS指导下置入支架者的TVF发生率低于造影指导下置入支架者[8.3%(15/180)比16.0%(27/169),P=0.03]。而非CKD组共81例发生TVF,其中IVUS指导下置入支架者的TVF发生率与造影指导下置入支架者差异无统计学意义[5.9%(32/543)比8.9%(49/551),P=0.06],不存在交互作用(P=0.47)。多因素Cox回归分析结果显示,IVUS指导(HR=0.56,95%CI 0.39~0.81,P=0.002)、CKD(HR=1.83,95%CI 1.17~2.87,P=0.010)和支架长度(每增加10 mm)(HR=1.11,95%CI 1.04~1.19,P=0.002)是置入DES术后3年发生TVF的独立影响因素。结论对于置入DES的冠心病患者,合并CKD者术后3年的TVF发生风险高于非CKD患者;相比于冠状动脉造影,IVUS指导DES置入可以降低CKD患者的TVF风险。  相似文献   
63.
Primary skin epidermal cells isolation and in vitro expansion culture have been widely used for laboratory research and clinical applications. The conventional methods involving sequential enzymatic digestion of adult tissues have given low cell recovery rate and reduced cell viability. We report here an advanced method for human primary epidermal progenitor cells isolation from skin tissues including the Rho kinase inhibitor Y‐27632. Compared with traditional protocols, the current protocol is simple, easy, and faster; moreover, it gives a greater yield of integrin‐expressing epithelial stem cells. In addition, our new methodology does not require a separation of epidermis from dermis because the medium selectively blocks focal adhesion and growth of dermal cells. Importantly, the cells isolated from this method can maintain their regeneration potential and quickly reconstitute a mature human skin in vivo after grafting onto nude mice. In brief, we describe here a simple (one step) and serum‐free method for isolating primary epidermal stem cells from adult tissues. The isolated cells may be widely used for both laboratory studies and clinical application, especially in the field of tissue engineering and regeneration.  相似文献   
64.
Objectives. We describe the impact of the Step On It! intervention to link taxi drivers, particularly South Asians, to health insurance enrollment and navigate them into care when necessary.Methods. Step On It! was a worksite initiative held for 5 consecutive days from September 28 to October 2, 2011, at John F. Kennedy International Airport in New York City. Data collected included sociodemographics, employment, health care access and use, height, weight, blood pressure, and random plasma glucose. Participants were given their results, counseled by a medical professional, and invited to participate in free workshops provided by partner organizations.Results. Of the 466 drivers participated, 52% were uninsured, and 49% did not have a primary care provider. Of 384 drivers who had blood pressure, glucose, or both measured, 242 (63%) required urgent or regular follow-up. Of the 77 (32%) requiring urgent follow-up, 50 (65%) sought medical care at least once, of whom 13 (26%) received a new diagnosis. Of the 165 (68%) requiring regular follow-up, 68 (41%) sought medical care at least once, of whom 5 (7%) received a new diagnosis.Conclusions. This study provides encouraging results about the potential impact of an easy-to-deliver, easily scalable workplace intervention with a large, vulnerable population.New York City alone has more than 50 000 yellow taxi drivers and a similar number of livery drivers.1 A large majority, 94%, are immigrants, mainly originating from India, Bangladesh, Pakistan, Haiti, and West African countries.1 Taxi drivers are often at greater risk for cardiovascular disease (CVD) and associated risk factors than the general population.2,3 Studies looking exclusively at taxi drivers have found a correlation between the occupation and myocardial infarctions, multivessel disease, obesity, insulin resistance, high blood pressure, high triglycerides, and high low-density lipoproteins.3 By nature of their occupation, drivers have a sedentary lifestyle.4,5 Sedentariness in the general population has been linked to a higher CVD mortality rate, secondary to coronary heart disease, sudden heart failure, hypertension, and diabetes.6–11 Environmental exposures are also to blame for high CVD and lung cancer risk for taxi drivers. Exposure to particulate matter, which is often found at high levels in closed vehicles, has been linked to lower heart rate variability, a predictor of CVD, and to lung cancer.12–14Other factors, such as high stress, poor working conditions, long hours, unstable income, unhealthy diet, significant concern about personal safety on the job, and institutional and organizational barriers further contribute to poorer health among taxi drivers.5,15–17 Several reports and studies on the working and living conditions of taxi drivers have been released in California; Chicago, Illinois; and New York City and described similar health profiles for this population.5,15,16 In New York City, drivers typically work 10- to 12-hour shifts 6 days a week.4,16,18 Studies have also shown that a major systems-level obstacle for taxi drivers is lack of adequate health care; 60% of taxi drivers were found to be uninsured in a Chicago study19 and 52% in a New York City study.20 The occupation-related barriers to care experienced by this largely immigrant community are further exacerbated by literacy and language barriers, financial pressures, family obligations, and cultural values.4,19,21 South Asian taxi drivers, the largest group of yellow taxi drivers in New York City, potentially face a double burden for CVD because of both the nature of their occupation and the increased CVD risk associated with South Asian ethnicity.22–27Several studies have demonstrated the successful use of occupation-based interventions to effect lifestyle changes.17,28–31 A literature review of dietary promotion programs in the workplace demonstrated that, with industry cooperation and use of a social–ecological model of intervention, worksite interventions can have gradual and favorable results.17 In one social–ecological study, changes to workplace cafeteria food service in conjunction with behavioral interventions for workers resulted in a significant increase in fruit and vegetable consumption among participants.17 Support from workplace management was crucial for the success of this program.17 Although a paucity of data exist on interventions specifically for US taxi drivers, a number of European studies have had good results for exercise and diet interventions for taxi and other drivers.29–31 A British pilot study used a peer video to encourage drivers to make healthy lifestyle changes over a 1-year study period, resulting in 73% of participating drivers reporting a significant lifestyle change, with greater physical activity, positive diet changes, and more time spent on family activities.29 Another British study used a peer education model for CVD risk education. Peer “health champions” disseminated information about free screenings and medical referrals; more than 66% of those who received medical appointments at screenings subsequently attended them.30 In Sweden, a healthy eating workplace intervention conducted at rest stops resulted in improved nutritional balance in meal choices among truck drivers.31 The results of these studies suggest that the workplace can be an effective setting for taxi driver health interventions in the United States.28The Immigrant Health and Cancer Disparities Service (IHCD) at Memorial Sloan-Kettering Cancer Center designed and implemented a taxi driver workplace health intervention, Step On It!, in 2011 at the John F. Kennedy (JFK) International Airport yellow cab holding lot in New York City. The Step On It! intervention incorporates specific components addressing drivers’ barriers to care, including
  1. health insurance enrollment education and enrollment assistance to address lack of health insurance;
  2. referrals to low-cost or free health clinics and hospitals to address financial barriers to obtaining health insurance;
  3. referrals to culturally and linguistically appropriate care to address language and cultural barriers;
  4. events held during work hours, providing a window of opportunity, and assistance with finding clinics with flexible hours, to address drivers’ long work hours; and
  5. onsite health screening and counseling with triage to urgent or regular follow-up to address lack of knowledge related to current health status and need for care.
After drivers were assessed for health care access and utilization, medical history, and CVD risk factors; screened for hypertension and elevated random plasma glucose; and measured for body mass index (BMI), Step On It! used a health care access navigation and case management intervention to link drivers to health insurance enrollment and navigate them into care when necessary. We describe the impact of this intervention on the primary outcome of interest, drivers’ engagement in needed medical care.  相似文献   
65.
王剑  谢飞  刘先齐  赵建军  李茂生  冷通国  林洪伟 《重庆医学》2015,(8):1063-1065,1068
目的:通过分组对照实验,探讨氨甲环酸的不同使用方式对全髋关节置换术(THA)显隐性失血的影响。方法病例选自该院骨科2010年3月至2013年8月共60例患者。诊断:股骨颈骨折47例,股骨头坏死13例;年龄45~82岁,平均62岁,均接受单侧T H A。所有病例分为A组、B组和C组共3组,各20例,经过筛选,每组男性6例,女性14例,均为初次全髋置换。A组术前0.5 h、术后3 h分别予100 mL生理盐水静滴;B组术前0.5 h将氨甲环酸按10 mg/kg稀释于100 mL生理盐水中静滴,术后3 h予100 mL生理盐水静滴;C组术前0.5 h、术后3 h分别将氨甲环酸按10 mg/kg稀释于100 mL生理盐水中静滴。计算各组患者的显性及隐性失血量,并进行统计学分析,探讨实验组中氨甲环酸2种使用方式的有效性及安全性。结果显性红细胞丢失量:A组(196.20±44.45)m L ,B组(114.84±35.21)m L ,C组(104.47±30.01)m L ;隐性红细胞丢失量:A组(614.50±98.41)m L ,B组(425.74±70.01)m L ,C组(337.12±52.23)m L。结论氨甲环酸的使用能明显减少T H A的显隐性失血量,术前0.5h合并术后3h使用较术前0.5h使用对减少隐性失血量效果更佳,进一步减少输血量,且不会明显增加下肢深静脉血栓形成的发生率。  相似文献   
66.
Zhang  Lixi  Zhu  Huiyi  Yang  Pinting  Duan  Xinwang  Wei  Wei  Wu  Zhenbiao  Fang  Yongfei  Li  Qin  Liu  Shengyun  Shi  Xiaofei  Li  Hongbin  Wu  Chanyuan  Zhou  Shuang  Leng  Xiaomei  Zhao  Jiuliang  Xu  Dong  Wu  Qingjun  Tian  Xinping  Li  Mengtao  Zhao  Yan  Wang  Qian  Zeng  Xiaofeng 《Clinical rheumatology》2021,40(11):4597-4608
Clinical Rheumatology - This study aimed to investigate the associated factors of myocardial involvements (MIs) in patients with idiopathic inflammatory myopathies (IIMs). In this multi-center...  相似文献   
67.
目的:探讨半导体激光照射联合药物治疗及护理治疗Ⅱ-Ⅲ期褥疮的疗效。方法:将40例外院带入褥疮的老龄重症患者随机分成试验组和对照组,各20例。对照组按内科护理常规,清洁创面后盐酸左氧氟沙星眼用凝胶;试验组清创后每天用半导体激光照射褥疮表面20min,用盐酸左氧氟沙星眼用凝胶涂于患处,再用人工细胞愈合膜涂于患处,并给予有针对性的护理干预。结果:治疗4周后观察褥疮愈合情况。对照组有效率为69.8%,试验组有效率为90.1%。两组差异比较(P<0.05),有统计学意义。半导体激光联合药物治疗及护理有利于Ⅱ-Ⅲ期于褥疮的肉芽组织生长和上皮爬行,促进褥疮创面愈合,并缩短了褥疮愈合时间。  相似文献   
68.
The Terumo stent is a new, balloon-expandable, stainless-steel device with a unique multicellular design to provide robust radial force and end-stoppers to prevent dislodgement. We evaluated the early and late clinical and angiographic outcomes of Terumo coronary stent implantation in native coronary arteries using an open, nonrandomized 3-center registry. From July 1998 to June 1999, a total of 118 Terumo stents were implanted in 105 patients (mean age, 58 +/- 10 years). A significant proportion of patients suffered from diabetes (34%), prior myocardial infarction (MI; 43%) and unstable angina (31%). Most target lesions (48%) had unfavorable morphological characteristics (type B2 or C); mean reference luminal diameter was 2.76 +/- 0.41 mm and lesion length was 11.4 +/- 5.3 mm. Primary success in stent deployment was achieved in 103 patients (98%). There was 1 patient with acute stent thrombosis in whom 2 overlapping stents were deployed. Following stenting, the minimal luminal diameter increased from 1.04 +/- 0.48 mm to 2.39 +/- 0.33 mm. Six-month angiography was performed in 97 patients (92%), and the binary angiographic restenosis (> or = 50% narrowing) rate was 16%. Late loss index was 0.50 +/- 0.43. By 6 months, two patients (1.9%) died, two patients (1.9%) had Q-wave MI and 9 patients (8.4%) required repeat coronary interventions. Therefore, our study shows that the Terumo stent is potentially safe and efficacious in the treatment of coronary narrowings, even in the presence of unfavorable clinical conditions and complex lesion morphological characteristics.  相似文献   
69.
OBJECTIVE: To assess the potential role of conventional sonography and colour flow Doppler (CFD) sonography (CFDS) in the differential diagnosis of toxic multinodular goitres. SUBJECTS AND METHODS: We investigated 55 patients with untreated hyperthyroidism (24 with typical toxic diffuse goitre of Graves' disease (Group A); 26 with multinodular goitre (Group B); and five with single toxic adenoma (Group C); 22 euthyroid subjects (12 with non-toxic multinodular goitre (Group D) and ten normal subjects (Group E)) were included as controls. In all cases free thyroxine, free tri-iodothyronine, TSH, TSH receptor antibodies (TRAb), anti-thyroperoxidase antibody, anti-thyroglobulin antibodies and anti-thyroid microsomal antibodies were determined and a [(99m)Tc]pertechnetate thyroid scan was performed. RESULTS: Patients with toxic multinodular goitre displayed two different CFDS patterns: 18 patients (Group B-1) had nodules with normal vascularity surrounded by diffuse parenchymal hypoechogenicity with markedly increased CFD signal and maximal peak systolic velocity (PSV) (a pattern similar to Group A patients with Graves' disease); eight patients (Group B-2) had increased intra- and perinodular CFD signal and PSV with normal extranodular vascularity (a pattern similar to that found in Group C patients with single toxic adenoma). Patients of Group B-1 showed a proportion of clinically evident thyroid ophthalmopathy, positive TRAb and other thyroid autoantibodies similar to that observed in Group A patients, while no evidence of thyroid autoimmunity was found in Group B-2. Sixteen out of 18 (89%) patients from Group B-1 displayed a scintiscan pattern of diffuse uneven radionuclide distribution, while seven out of eight (87.5%) of those from Group B-2 had localized uptake in multiple discrete nodules. Taken together, these data strongly suggest that Group B-1 mostly represents patients with the multinodular variant of Graves' disease, while Group B-2 represents patients with non-autoimmune toxic multinodular goitre. CONCLUSIONS: This study shows that combined conventional sonography and CFDS may easily distinguish nodular variants of Graves' disease from non-autoimmune forms of toxic multinodular goitre and confirms the clinical usefulness of this technique in the first-line evaluation of hyperthyroid patients.  相似文献   
70.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号